Creo Medical Group PLC (AIM:CREO)
London · Delayed Price · Currency is GBP · Price in GBX 13.53
-0.10 (-0.70%)
Jul 27, 2026, 3:27 PM GMT
Creo Medical Group Market Cap
Creo Medical Group has a market cap or net worth of 61.76 million as of July 27, 2026. Its market cap has increased by 9.60% in one year.
Market Cap
61.76M
Enterprise Value
53.46M
Revenue
6.00M
Ranking
n/a
PE Ratio
11.65
Stock Price
13.53
ChartMarket Cap Chart
Since December 9, 2016, Creo Medical Group's market cap has decreased from 64.46M to 61.76M, a decrease of -4.19%. That is a compound annual growth rate of -0.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 61.76M | 54.99% |
| Dec 31, 2025 | 39.84M | -49.19% |
| Dec 31, 2024 | 78.42M | -51.05% |
| Dec 29, 2023 | 160.20M | 255.34% |
| Dec 30, 2022 | 45.08M | -83.01% |
| Dec 31, 2021 | 265.37M | -13.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 9, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 196.51B |
| GSK plc | 76.44B |
| Haleon | 32.02B |
| Smith & Nephew | 9.59B |
| Bioventix | 79.68M |
| Ondine Biomedical | 71.44M |
| ECO Animal Health Group | 68.44M |
| Shield Therapeutics | 65.71M |